ArticleGigaScience2025
Overture: an open-source genomics data platform.
Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The ICGC ARGO data dictionary for standardizing global cancer clinical data.Scientific data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Funding
Abstract
backgroundNext-generation sequencing has created many new technological challenges in organizing and distributing genomics datasets, which now can routinely reach petabyte scales. Coupled with data-hungry artificial intelligence and machine learning applications, findable, accessible, interoperable, and reusable genomics datasets have never been more valuable. While major archives like the Genomics Data Commons, Sequence Reads Archive, and European Genome-Phenome Archive have improved researchers' ability to share and reuse data, and general-purpose repositories such as Zenodo and Figshare provide valuable platforms for research data publication, the diversity of genomics research precludes any one-size-fits-all approach. In many cases, bespoke solutions are required, and despite funding agencies and journals increasingly mandating reusable data practices, researchers still lack the technical support needed to meet the multifaceted challenges of data reuse.
findingsOverture bridges this gap by providing open-source software for building and deploying customizable genomics data platforms. Its architecture consists of modular microservices, each of which is generalized with narrow responsibilities that together combine to create complete data management systems. These systems enable researchers to organize, share, and explore their genomics data at any scale. Through Overture, researchers can connect their data to both humans and machines, fostering reproducibility and enabling new insights through controlled data sharing and reuse.
conclusionsBy making these tools freely available, we can accelerate the development of reliable genomic data management across the research community quickly, flexibly, and at multiple scales. Overture is an open-source project licensed under AGPLv3.0 with all source code publicly available from https://github.com/overture-stack and documentation on development, deployment, and usage available from www.overture.bio.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.